TUDOR INVESTMENT CORP ET AL

Position in BHC — Bausch Health Companies Inc.

CIK 923093 STAMFORD, CT

Position in BHC

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$63,720

-$18,290 QoQ

Shares Held

11,800

0.0% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

9 quarters on record

Voting authority Sole 50.ToString("F0")% Shared 50.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

TUDOR INVESTMENT CORP ET AL holds $23,421,840 across 9 Drug Manufacturers - Specialty & Generic names. BHC ranks #8 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TEVA	Teva Pharmaceutical Industries Ltd	544,501	$16,400,370
2	VTRS	Viatris Inc	276,210	$3,731,597
3	LQDA	Liquidia Corp	40,263	$1,519,525
4	XERS	Xeris Biopharma Holdings, Inc.	107,414	$623,001
5	COLL	Collegium Pharmaceutical, Inc	13,956	$461,524
6	AMLX	Amylyx Pharmaceuticals, Inc.	31,334	$435,542
7	ORGO	Organogenesis Holdings Inc.	63,580	$150,684
8	BHC	Bausch Health Companies Inc. This page	11,800	$63,720

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$63,720	11,800	0.0%	Shares	Defined	2026-05-15
2025-12-31	$82,010	11,800	+13.2%	Shares	Defined	2026-02-17
2023-12-31	$83,592	10,423	-39.3%	Shares	Defined	2024-02-14
2023-09-30	$141,178	17,175	-49.7%	Shares	Defined	2023-11-15
2022-12-31	$214,543	34,163	0.0%	Shares	Defined	2023-02-14
2022-09-30	$235,383	34,163	+194.0%	Shares	Defined	2022-11-14
2021-12-31	$320,855	11,621	-22.2%	Shares	Defined	2022-02-14
2021-09-30	$416,134	14,942	+107.0%	Shares	Defined	2021-11-17
2021-03-31	$229,131	7,219	—	Shares	Defined	2021-05-17
No filing history on record for this holder in this stock.